Public and professional awareness of
the risk factors for, and the symptoms of, diabetes are an
important step towards its control and prevention.
Diabetes prevention can be categorized into two groups:
Primary prevention
Secondary prevention
Primary Prevention
Primary prevention identifies and protects
susceptible individuals from developing diabetes. It therefore
has an impact by reducing both the need for diabetes care
and the need to treat diabetes-related complications.
While there is yet no conclusive evidence
to suggest that type 1 diabetes can be prevented, primary
prevention of type 2 diabetes is potentially possible.
Lifestyle changes aimed at weight control
and increased physical activity are important objectives in
the prevention of type 2 diabetes in children and adults alike.
The benefits of reducing body weight and increasing physical
activity are not confined to type 2 diabetes; they also play
a role in reducing heart disease, high blood pressure, etc.
Secondary Prevention
Secondary prevention involves the early
detection and prevention of complications, therefore reducing
the need for treatment. Action taken early in the course of
diabetes is more beneficial in terms of quality of life and
is more cost-effective, especially if this action can prevent
hospital stays.
There is now conclusive evidence that good
control of blood glucose levels can substantially reduce the
risk of developing complications and slow their progression
in all types of diabetes. The management of high blood pressure
and raised blood lipids (fats) is equally important.
Prevention in
Developing Countries
As the developing world is expected
to bear the brunt of the escalating epidemic in the future,
diabetes prevention is proving especially urgent and difficult
in developing countries.
In most developing countries, health policies
and services need to put more emphasis on non-communicable
diseases such as diabetes, but in many of these countries
(as well as in developed ones) decision makers lack awareness
of diabetes and the political will to invest in prevention.
The resources required for future research need to be found.
Standards in diabetes monitoring and surveillance need to
be set in countries where progress has been limited.